Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 8/20 | 0.50 |
| ▸ | THRB | P10828 | 6/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | THRA | P10827 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11107036 | 0.98 | ALDH1A1 (0.57) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Hydrochloric Acid SCHEMBL28271407 | 0.96 | ALDH1A1 (0.55) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Dimethylamine SCHEMBL6114524 | 0.94 | ALDH1A1 (0.53) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Ethylene Glycol SCHEMBL230725 | 0.94 | ALDH1A1 (0.59) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| N,N-Dimethylethanaminium SCHEMBL3206264 | 0.88 | ALDH1A1 (0.48) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL29221164 | 0.87 | ALDH1A1 (0.47) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL39919 | 0.86 | ALDH1A1 (0.59) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL262028 | 0.86 | ALDH1A1 (0.59) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL19660295 | 0.86 | ALDH1A1 (0.59) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL25007355 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713399-A1 | WATERBORNE ACRYLIC COATING COMPOSITION | SWIMC LLC (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4709768-A1 | BIOBASED LATEX HAVING INCREASED C14 CONTENT, METHODS OF MAKING AND METHODS OF USING | SWIMC LLC (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260062558-A1 | COATINGS COMPRISING SILICATE | SWIMC LLC (US) | 2026-03-05 | — | — | US | claimed |
| EP-4688968-A1 | A WATERBORNE SINGLE STAGE ACRYLIC LATEX WITH SUBSTANTIALLY NO COALESCING AGENTS AND COATINGS FORMED THEREFROM | SWIMC LLC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4413055-B1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | LUBRIZOL ADVANCED MAT INC (US) | 2025-12-03 | — | — | EP | claimed |
| EP-4601858-A1 | METHOD FOR THREE-DIMENSIONAL PRINTING OF FIBER COMPOSITE MATERIALS | MOI COMPOSITES S.r.l. (IT) | 2025-08-20 | — | — | EP | claimed |
| CN-120018945-A | Three-dimensional printing method for fiber composite material | MOI复合材料有限责任公司 | 2025-05-16 | — | — | CN | claimed |
| US-20250002704-A1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-01-02 | — | — | US | claimed |
| WO-2024242911-A1 | WATERBORNE ACRYLIC COATING COMPOSITION | SWIMC LLC (US) | 2024-11-28 | — | — | WO | claimed |
| US-20240384127-A1 | WATERBORNE ACRYLIC RESIN CONTAINING INORGANIC CROSSLINKING AGENT, LATEX CONTAINING THE SAME AND COATINGS FORMED FROM THE SAME | SWIMC LLC | 2024-11-21 | — | — | US | claimed |
| EP-0350354-B1 | Light valve incorporating a suspension stabilized with a block polymer | RESEARCH FRONTIERS INC (US) | 1994-06-01 | — | — | EP | claimed |
| US-5098952-A | Acrylate copolymers with hydroxyalkyl acrylate or methacrylate for high glass transition temperature | S. C. JOHNSON & SON, INC. (US) | 1992-03-24 | — | — | US | claimed |
| US-5032658-A | Hardness, unsaturated ester | POLYMER TECHNOLOGY CORPORATION (US) | 1991-07-16 | — | — | US | claimed |
| EP-0424099-A2 | Method of Preparing Polymeric Compositions for Oxygen Permeable Contact Lenses | POLYMER TECHNOLOGY CORPORATION (US) | 1991-04-24 | — | — | EP | claimed |
| EP-0350354-A2 | Light valve incorporating a suspension stabilized with a block polymer | RESEARCH FRONTIERS INCORPORATED (US) | 1990-01-10 | — | — | EP | claimed |
| EP-0057535-B1 | FLAME RETARDANT POLYMER SYSTEMS AND COMPOSITIONS | OCCIDENTAL CHEMICAL CORPORATION (US) | 1985-07-31 | — | — | EP | claimed |
| US-4508884-A | COPOLYMER OF UNSATURATED SILICONE ESTER, UNSATURATED ESTER, HYDROP | COOPERVISION, INC. (US) | 1985-04-02 | — | — | US | claimed |
| EP-0126866-A1 | Organic amine salt of an acid, manufacture and use as accelerator | DENTSPLY INTERNATIONAL, INC. (US) | 1984-12-05 | — | — | EP | claimed |
| US-4367315-A | HEXACHLOROBICYCLO (2.2.1) HEPTENE DICARBOXYLIC ACID COMPONENT | OCCIDENTAL CHEMICAL CORPORATION (US) | 1983-01-04 | — | — | US | claimed |
| EP-0057535-A1 | Flame retardant polymer systems and compositions | OCCIDENTAL CHEMICAL CORPORATION (US) | 1982-08-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002704-A1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | SORD, SCD, DEGS1 | ALDH1A1 2367/4885TP53 790/4885HIF1A 3446/4885 |
| US-20260062558-A1 | COATINGS COMPRISING SILICATE | ALG3, MACF1, ILK | ALDH1A1 2378/4885TP53 3237/4885HIF1A 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.